๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
101.50
-10.00 (-8.97%)
Nov 20, 2026, 1:30 PM CST

Lotus Pharmaceutical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
31,08020,50918,58416,95814,63312,649
Revenue Growth
66.59%10.36%9.59%15.89%15.68%17.90%
Gross Profit
16,07211,90710,9249,3847,8065,640
Operating Income
6,9466,2076,1805,0824,2492,529
Net Income
2,2234,7205,0664,1063,0211,403
Earnings Per Share
8.4017.8118.9815.4711.395.40
EPS Growth
-52.82%-6.19%22.72%35.79%110.97%29.62%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Segment
559.68420.3333.96339.39301.39236.11
Pharmaceuticals Segment
30,97420,35218,46916,86414,50312,526
Elimination
-453.44-263.02-218.95-245.38-171.32-112.78
Total
31,08020,50918,58416,95814,63312,649

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
7,2597,7406,0301,7711,9831,605
Total Debt
58,95355,93413,66711,5858,9186,944
Net Cash (Debt)
-51,694-48,194-7,636-9,814-6,935-5,339
Net Cash Growth
------
Net Cash Per Share
-195.22-181.84-28.62-36.97-26.16-20.53

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3,8377,4826,1551,6143,719119.66
Capital Expenditures
-1,526-1,320-353.84-410.57-577.16-572.73
Free Cash Flow
2,3116,1625,8011,2043,142-453.07
Free Cash Flow Growth
-68.49%6.23%381.96%-61.70%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
51.71%58.05%58.78%55.34%53.35%44.59%
Operating Margin
22.35%30.26%33.25%29.97%29.04%19.99%
Pretax Margin
9.25%27.88%34.22%30.09%26.93%14.78%
Profit Margin
7.15%23.01%27.26%24.21%20.64%11.09%
FCF Margin
7.44%30.05%31.21%7.10%21.47%-3.58%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
2.5322.5325.6564.6003.4161.905
Dividend Per Share Growth
-55.03%-55.23%22.96%34.68%79.28%451.43%
Dividend Yield
2.50%0.91%2.13%1.71%1.41%1.98%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
12.0815.7714.1217.5221.3418.22
Forward PE
7.3811.0512.0515.3618.3915.41
P/FCF Ratio
11.7012.0812.3359.7720.52-
PS Ratio
0.873.633.854.244.412.02